Explore the words cloud of the PELICO project. It provides you a very rough idea of what is the project "PELICO" about.
The following table provides information about the project.
Coordinator |
ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE
Organization address contact info |
Coordinator Country | Ukraine [UA] |
Project website | http://pelico.org/ |
Total cost | 688˙500 € |
EC max contribution | 688˙500 € (100%) |
Programme |
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) |
Code Call | H2020-MSCA-RISE-2015 |
Funding Scheme | MSCA-RISE |
Starting year | 2016 |
Duration (year-month-day) | from 2016-01-01 to 2019-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE | UA (KYIV) | coordinator | 409˙500.00 |
2 | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE | UK (CAMBRIDGE) | participant | 108˙000.00 |
3 | LATVIJAS ORGANISKAS SINTEZES INSTITUTS | LV (RIGA) | participant | 103˙500.00 |
4 | KARLSRUHER INSTITUT FUER TECHNOLOGIE | DE (KARLSRUHE) | participant | 67˙500.00 |
The expertise, resources and specific knowledge of all participating parties will be combined to achieve a breakthrough in design, synthesis and application of peptide analogues (peptidomimetics) possessing photo-controlled biological activities, with special emphasis on anti-microbial and anti-cancer activities. The main idea behind the Project consists in chemical incorporation of artificial photo-controllable building blocks into known biologically active peptides by replacing their natural building blocks – the amino acid residues. Such a modification would provide photocontrolled peptidomimetics which can reversibly change their structure between two different photo-forms upon irradiation with light of different wavelength. The participating parties possess general know-how for design of the peptidomimetics which can exist in two photo-forms, biologically active and inactive ones, reversibly interconvertible by light of different wavelength. This opens a possibility to convert inactive peptidomimetics to active compounds by irradiation with physiologically benign light directly in tissues with very high spatiotemporal precision and can be a fundamental basis of new therapeutic strategies. The research staff exchange and other activities planned under the Project will be dedicated to accomplish four complementary work packages: (i) carrying out pharmacokinetic and toxicity studies of the photocontrolled peptidomimetics synthesized by the parties previously; (ii) evaluation of novel photocontrolled building block chemotypes for their compatibility with peptides; (iii) creation of new photocontrolled peptidomimetics, especially based on the novel building blocks and the know-how developed by the parties (e.g. using “stapled peptides” technology); (iv) multidisciplinary training of the researchers whose future work will be aimed at further development of the most advanced photocontrolled peptidomimetics as drugs suitable for photodynamic therapy.
Reports on biological activity studies | Documents, reports | 2020-03-20 15:18:12 |
Novel photocontrollable building blocks | Other | 2020-03-20 15:18:12 |
manuscript 4 | Documents, reports | 2020-03-20 15:18:12 |
Manuscript 2 | Documents, reports | 2020-03-20 15:18:12 |
Manuscript 3 | Documents, reports | 2020-03-20 15:18:12 |
Manuscript 1 | Documents, reports | 2020-03-20 15:18:12 |
Project web-site | Websites, patent fillings, videos etc. | 2020-03-20 15:18:12 |
Take a look to the deliverables list in detail: detailed list of PELICO deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2020 |
Oleg Babii, Sergii Afonin, Tim Schober, Liudmyla V Garmanchuk, Liudmyla I Ostapchenko, Volodymyr Yurchenko, Sergey Zozulya, Oleksandr Tarasov, Iryna Pishel, Anne S Ulrich, Igor V Komarov Peptide drugs for photopharmacology: how much of a safety advantage can be gained by photocontrol? published pages: , ISSN: 2631-3316, DOI: 10.4155/fdd-2019-0033 |
Future Drug Discovery | 2020-03-20 |
2020 |
Sergii Afonin, Oleg Babii, Aline Reuter, Volker Middel, Masanari Takamiya, Uwe Strähle, Igor V Komarov, Anne S Ulrich Light-controllable dithienylethene-modified cyclic peptides: photoswitching the in vivo toxicity in zebrafish embryos published pages: 39-49, ISSN: 1860-5397, DOI: 10.3762/bjoc.16.6 |
Beilstein Journal of Organic Chemistry 16 | 2020-03-20 |
2019 |
Tim Schober, Ilona Wehl, Sergii Afonin, Oleg Babii, Anna Iampolska, Ute Schepers, Igor V. Komarov, Anne S. Ulrich Controlling the Uptake of Diaryletheneâ€Based Cellâ€Penetrating Peptides into Cells Using Light published pages: , ISSN: 2367-0932, DOI: 10.1002/cptc.201900019 |
ChemPhotoChem | 2020-03-20 |
2018 |
Alexander V. Strizhak, Krishna Sharma, Oleg Babii, Sergii Afonin, Anne S. Ulrich, Igor V. Komarov, David R. Spring Highly reactive bis-cyclooctyne-modified diarylethene for SPAAC-mediated cross-linking published pages: , ISSN: 1477-0520, DOI: 10.1039/c8ob02428f |
Organic & Biomolecular Chemistry | 2020-03-20 |
2018 |
Oleg Babii, Sergii Afonin, Aleksandr Yu. Ishchenko, Tim Schober, Anatoliy O. Negelia, Ganna M. Tolstanova, Liudmyla V. Garmanchuk, Liudmyla I. Ostapchenko, Igor V. Komarov, Anne S. Ulrich Structure–Activity Relationships of Photoswitchable Diarylethene-Based β-Hairpin Peptides as Membranolytic Antimicrobial and Anticancer Agents published pages: 10793-10813, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.8b01428 |
Journal of Medicinal Chemistry 61/23 | 2020-03-20 |
2017 |
Oleg Babii, Sergii Afonin, Tim Schober, Igor V. Komarov, Anne S. Ulrich Flexibility vs rigidity of amphipathic peptide conjugates when interacting with lipid bilayers published pages: 2505-2515, ISSN: 0005-2736, DOI: 10.1016/j.bbamem.2017.09.021 |
Biochimica et Biophysica Acta (BBA) - Biomembranes 1859/12 | 2020-03-20 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PELICO" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PELICO" are provided by the European Opendata Portal: CORDIS opendata.